12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several healthcare stocks experienced significant movements. Acutus Medical (AFIB) saw a substantial increase of 49.2%, while Kazia Therapeutics (KZIA) and Sunshine Biopharma (SBFM) also posted notable gains. On the downside, SINTX Techs (SINT) and GlycoMimetics (GLYC) experienced declines, along with other stocks such as Cingulate (CING) and Tharimmune (THAR). These movements reflect changes in investor sentiment and can impact the short-term performance of these stocks.
January 24, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
GlycoMimetics' shares fell by 7.47% to $2.85, with a market cap of $183.5 million.
The decline in GLYC's stock price could reflect short-term bearish sentiment among investors, potentially leading to further losses.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
SINTX Techs' stock declined by 14.2% to $0.27, with a market cap of $1.1 million.
The notable decline in SINT's stock price suggests negative investor sentiment, which may lead to further short-term depreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Acutus Medical's stock rose 49.2% to $0.34, with a market cap of $9.9 million.
The significant after-market gain for AFIB indicates strong positive investor sentiment, which could lead to continued short-term upward price momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Kazia Therapeutics' stock increased by 25.88% to $0.44, with a market cap of $11.6 million.
The after-market rise in KZIA's stock price suggests positive momentum that could persist in the short term.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Sunshine Biopharma's shares increased by 25.0% to $0.3, with a market cap of $7.7 million.
The 25% rise in SBFM's stock price could indicate a bullish trend for the short term, driven by investor interest.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100